PFE Dec 2025 22.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:54AM EDT. Market open.
| Previous close | 7.64 |
| Open | 7.78 |
| Bid | 8.05 |
| Ask | 8.40 |
| Strike | 22.50 |
| Expiry date | 2025-12-19 |
| Day's range | 7.78 - 8.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 791 |
ReutersFormer Pfizer CEO, CFO say they will not be involved in Starboard's campaign against drugmaker
"We have decided not to be involved in the efforts of Starboard Value regarding Pfizer," the executives said in a statement on Wednesday, which was issued by Guggenheim Partners, an advisor to Pfizer. "We are fully supportive of Pfizer Chairman & CEO Albert Bourla, senior management and the board, and we are confident that over time they will deliver shareholder value."
GuruFocus.comCardiff Oncology Inc (CRDF) Q2 2024 Earnings Call Highlights: Strategic Trials and Financial ...
Cardiff Oncology Inc (CRDF) advances its clinical trials with promising results and maintains a strong cash position to support future growth.
- GuruFocus.com
Atea Pharmaceuticals Inc (AVIR) Q2 2024 Earnings Call Highlights: Strong Financial Position and ...
Atea Pharmaceuticals Inc (AVIR) reports a robust cash runway into 2027 and significant progress in COVID-19 and HCV clinical trials.
© 2024 Yahoo. All rights reserved.